Structure of TGN020
CAS No.: 51987-99-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 51987-99-6 |
Formula : | C8H6N4OS |
M.W : | 206.22 |
SMILES Code : | O=C(NC1=NN=CS1)C2=CN=CC=C2 |
MDL No. : | MFCD00708771 |
InChI Key : | AGEGZHOPKZFKBP-UHFFFAOYSA-N |
Pubchem ID : | 4173511 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Astrocytes in rat supraoptic nucleus brain slices | 10 µM | 10 minutes | To investigate the inhibitory effect of TGN-020 on VP neuronal activity under hyposmotic challenge. Results showed that TGN-020 blocked the rebound increase in firing rate of VP neurons induced by HOC. | Acta Physiol (Oxf). 2021 Jul;232(3):e13672 |
Primary astrocytes | 10 µM | 24 or 48 hours | TGN020 changed cell morphology, diminished cell proliferation and suppressed astrocyte activation | Neurotherapeutics. 2024 Mar;21(2):e00306 |
Astrocytes in brain slices | 10 µM | 30 minutes | To study the effect of TGN-020 on GFAP and AQP4 expression under OGD conditions, results showed that TGN-020 could partially block the OGD-induced decrease in GFAP expression. | ASN Neuro. 2020 Jan-Dec;12:1759091420960550 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Wistar rats | Streptozotocin-induced diabetic rat model | Intravitreal injection | 0.02 mg/μL | Single injection, evaluated after 48 hours | To investigate the effects of TGN-020 on diabetic retinal edema. Results showed that TGN-020 suppressed the expression of VEGF and AQP4 in diabetic rat retinas, reduced retinal thickness and vascular leakage. | Int J Mol Sci. 2020 Mar 27;21(7):2324 |
Wistar rats | Middle cerebral artery occlusion (MCAO) model | Microinjection into the SON | 10 μM | Single injection, observation for 8 hours | To study the effect of TGN-020 on MCAO-induced brain injury, results showed that TGN-020 could reduce MCAO-induced increases in pERK1/2 and AQP4 expression and decrease in GFAP expression. | ASN Neuro. 2020 Jan-Dec;12:1759091420960550 |
C57BL/6 mice | MPTP-induced PD mouse model | Intraperitoneal injection | 100 mg/kg | Single administration | To evaluate the inhibitory effect of TGN020 on AQP4 in the MPTP-induced PD mouse model and its impact on neuropathology. Results showed that TGN020 inhibited AQP4 expression, exacerbated astrogliosis, and further aggravated PD pathological manifestations. | J Adv Res. 2024 Feb;56:125-136 |
Male C57BL/6 mice | Collagenase-induced intracranial hemorrhage model | Intraperitoneal injection | 100 mg/kg | 30 minutes before each exosomes administration, continued until the end of the experiment | To evaluate the effect of TGN020 as an AQP4-specific inhibitor on H-Exo's promotion of intracranial lymphatic drainage and neurological recovery. Results showed that TGN020 successfully reversed H-Exo's ability to promote solute efflux and neurological recovery, indicating that H-Exo's effects depend on intact GLS function. | Fluids Barriers CNS. 2025 Apr 14;22(1):37 |
Sprague-Dawley rats | T13 spinal cord hemisection model | Intrathecal injection | 15 μg | Once a day for 7 consecutive days | TGN020 suppressed astrocyte activation, attenuated the development and maintenance of below-level CNP and promoted motor function recovery in vivo | Neurotherapeutics. 2024 Mar;21(2):e00306 |
Male Sprague-Dawley rats | Hyposmotic challenge model | Intraperitoneal injection | 20 mL/kg | Single injection, lasting 10-30 minutes | To investigate the regulatory effect of TGN-020 on VP neuronal activity under hyposmotic challenge in vivo. Results showed that TGN-020 blocked the rebound increase in firing rate of VP neurons induced by hyposmotic challenge. | Acta Physiol (Oxf). 2021 Jul;232(3):e13672 |
Mice | C57BL/6 mice | Superfusion | 20 μM | Continuous superfusion | TGN-020 was used to block AQP4 water channels to investigate its effect on light-evoked ECS α decrease. The results showed that TGN-020 had no effect on the light-evoked ECS α decrease. | Glia. 2022 Oct;70(10):1927-1937 |
C57BL/6J mice | Traumatic brain injury (TBI) model | Intraperitoneal injection | 200 mg/kg | Every 24 hours until mice sacrifice | To evaluate the effect of TGN020 on BBB integrity and astrocyte function after TBI, results showed that TGN020 significantly downregulated AQP4 expression, optimized BBB integrity and astrocyte function | Int J Biol Sci. 2022 Jan 1;18(1):441-458 |
Sprague-Dawley rats | Middle cerebral artery occlusion (MCAO) model | Intraperitoneal injection | 200 mg/kg | Single dose, administered 10 minutes after MCAO | To evaluate the effect of TGN-020 on brain edema and infarct volume after cerebral ischemia. Results showed that the TGN-020-treated group exhibited reduced infarct volumes and brain swelling at 1 day and 14 days after stroke, and better neurological recovery at 14 days. | Front Immunol. 2022 May 3;13:870029 |
C57/BL6 male mice | Middle cerebral artery occlusion (MCAO) model | Intraperitoneal injection | 200 mg/kg | Single dose, lasting 48 hours | TGN-020 alleviates inflammation and apoptosis after cerebral ischemia-reperfusion injury by improving glymphatic function and inhibiting the ERK1/2 pathway. | Mol Neurobiol. 2024 Feb;61(2):1175-1186 |
C57BL/6J mice | Traumatic brain injury (TBI) model | Intraperitoneal injection | 200 mg/kg | 22 consecutive days | TGN-020 significantly reduced the water content in the hippocampus and cortex of TBI mice and improved cognitive abilities. | Heliyon. 2023 Nov 13;9(11):e22035 |
Mice | RTg4510 transgenic mice | Intraperitoneal injection | 250 mg/kg | Single dose | To assess the effect of AQP4 inhibitor TGN-020 on CSF-ISF exchange and tau clearance in the brain. Results showed that TGN-020 significantly inhibited CSF-ISF exchange and tau clearance. | Brain. 2020 Aug 1;143(8):2576-2593 |
Mice | Chronic cerebral hypoperfusion model | Intraperitoneal injection | 250 mg/kg | Single dose | Inhibits AQP4 polarity, disrupts the polarized distribution of AQP4 in astrocytes, thereby inhibiting glymphatic system function. | Neurosci Bull. 2022 Feb;38(2):181-199 |
BALB/c mice | DSS-induced experimental colitis model | Intraperitoneal injection | 250 mg/kg | Once daily for 7 days | TGN-020 treatment effectively alleviated DSS-induced experimental colitis in mice and reduced apoptosis of colon epithelial cells | Cell Death Discov. 2022 Jun 28;8(1):298 |
C57BL/6 mice | Perioperative neurocognitive disorder (PND) mouse model | Intraperitoneal injection | 250 mg/kg | Single dose | TGN-020 further aggravated AQP4 depolarization in the hippocampus of PND mice, leading to exacerbated neuroinflammation and cognitive dysfunction. | J Cereb Blood Flow Metab. 2024 Aug;44(8):1450-1466 |
Mice | Traumatic brain injury (TBI) model | Intraperitoneal injection | 250 mg/kg | Single dose | TGN-020, a specific inhibitor of AQP4, was used for pharmacological blocking of the glymphatic system. The results showed that TGN-020 effectively blocked the glymphatic transport of RITC-dextran. | CNS Neurosci Ther. 2023 Dec;29(12):3876-3888 |
Male C57BL/6J mice | Healthy mice | Intraperitoneal injection | 400 mg/kg | Single dose, experiments conducted 30 minutes post-injection | To investigate the effect of AQP4 inhibitor TGN-020 on Aβ40 clearance. Results showed that TGN-020 significantly increased perivascular accumulation of Aβ40, indicating impaired perivascular clearance of Aβ40 due to AQP4 inhibition. | Mol Neurobiol. 2020 Nov;57(11):4720-4734 |
Mice | Tau propagation model | Intraperitoneal injection | 50 mg/kg | 3 doses/week for 10 weeks | To investigate the impact of long-term AQP4 inhibition on tau propagation, results showed TGN-020 treatment increased tau aggregation and transhemispheric spread in the brain. | Alzheimers Res Ther. 2024 Apr 5;16(1):71 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
4.85mL 0.97mL 0.48mL |
24.25mL 4.85mL 2.42mL |
48.49mL 9.70mL 4.85mL |
Tags: TGN-020 | TGN020 | TGN 020 | PROTAC Linkers | Aquaporin 4 | AQP4 | edema | glial | inhibitor | 51987-99-6 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL